Rutten FF - Search Results

1

Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care--the Triumph project.

Verhamme KM, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom MC, Artibani W, Begaud B, Berges R, Borkowski A, Chappel CR, Costello A, Dobronski P, Farmer RD, Jiménez Cruz F, Jonas U, MacRae K, Pientka L, Rutten FF, van Schayck CP, Speakman MJ, Sturkenboom MC, Tiellac P, Tubaro A, Vallencien G, Vela Navarrete R; Triumph Pan European Expert Panel. Verhamme KM, et al. Among authors: rutten ff. Eur Urol. 2002 Oct;42(4):323-8. doi: 10.1016/s0302-2838(02)00354-8. Eur Urol. 2002. PMID: 12361895

2

Medical consumption and costs during a one-year follow-up of patients with LUTS suggestive of BPH in six european countries: report of the TRIUMPH study.

van Exel NJ, Koopmanschap MA, McDonnell J, Chapple CR, Berges R, Rutten FF; TRIUMPH Pan-European Expert Panel. van Exel NJ, et al. Among authors: rutten ff. Eur Urol. 2006 Jan;49(1):92-102. doi: 10.1016/j.eururo.2005.09.016. Epub 2005 Nov 2. Eur Urol. 2006. PMID: 16314039

3

Lower urinary tract symptoms suggestive of benign prostatic obstruction--Triumph: health-economical analysis.

McDonnell J, Busschbach JJ, Kok E, van Exel J, Stolk E, Koopmanschap M, Rutten FF. McDonnell J, et al. Among authors: rutten ff. Eur Urol. 2001;39 Suppl 3:37-41. doi: 10.1159/000052566. Eur Urol. 2001. PMID: 11275741

4

The cost of atopic dermatitis in the Netherlands: an international comparison.

Verboom P, Hakkaart-Van L, Sturkenboom M, De Zeeuw R, Menke H, Rutten F. Verboom P, et al. Br J Dermatol. 2002 Oct;147(4):716-24. doi: 10.1046/j.1365-2133.2002.04964.x. Br J Dermatol. 2002. PMID: 12366418 Review.

5

A cost study of a general practitioner hospital in the Netherlands.

Hakkaart-van Roijen L, Moll van Charante EP, Bindels PJ, Yzermans CJ, Rutten FF. Hakkaart-van Roijen L, et al. Among authors: rutten ff. Eur J Gen Pract. 2004 Jun;10(2):45-9. doi: 10.3109/13814780409094231. Eur J Gen Pract. 2004. PMID: 15232523 Free article.

6

Standardisation of costs: the Dutch Manual for Costing in economic evaluations.

Oostenbrink JB, Koopmanschap MA, Rutten FF. Oostenbrink JB, et al. Among authors: rutten ff. Pharmacoeconomics. 2002;20(7):443-54. doi: 10.2165/00019053-200220070-00002. Pharmacoeconomics. 2002. PMID: 12093300

7

The societal costs and quality of life of patients suffering from bipolar disorder in the Netherlands.

Hakkaart-van Roijen L, Hoeijenbos MB, Regeer EJ, ten Have M, Nolen WA, Veraart CP, Rutten FF. Hakkaart-van Roijen L, et al. Among authors: rutten ff. Acta Psychiatr Scand. 2004 Nov;110(5):383-92. doi: 10.1111/j.1600-0447.2004.00403.x. Acta Psychiatr Scand. 2004. PMID: 15458562

8

Societal perspective on the burden of migraine in The Netherlands.

van Roijen L, Essink-Bot ML, Koopmanschap MA, Michel BC, Rutten FF. van Roijen L, et al. Among authors: rutten ff. Pharmacoeconomics. 1995 Feb;7(2):170-9. doi: 10.2165/00019053-199507020-00008. Pharmacoeconomics. 1995. PMID: 10155303

9

Update of the Dutch Manual for Costing in Economic Evaluations.

Tan SS, Bouwmans CA, Rutten FF, Hakkaart-van Roijen L. Tan SS, et al. Among authors: rutten ff. Int J Technol Assess Health Care. 2012 Apr;28(2):152-8. doi: 10.1017/S0266462312000062. Int J Technol Assess Health Care. 2012. PMID: 22559757

10

Economic analysis for clinical practice--the case of 31 national consensus guidelines in the Netherlands.

Niessen LW, Grijseels E, Koopmanschap M, Rutten F; Dutch Ministry of Health. Niessen LW, et al. J Eval Clin Pract. 2007 Feb;13(1):68-78. doi: 10.1111/j.1365-2753.2006.00662.x. J Eval Clin Pract. 2007. PMID: 17286726

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

173 results

Search Page

Filters